chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Redness on the thighs, legs, and chest. very little redness on my arm(s). I was watching tv 3 days after receiving the vaccine and my palms were suddenly blue and I could see every vein in  my hands and fingers. they were cold and color returned after submerging them in warm water.
Moderna COVID-19 Vaccine EUA Body/muscle aches, chills, low-grade fever, headache, and fatigue started around 12:24 am on 7/15/21, and lasted until midnight 7/16/21. Treated side effects with rest, liquids, Aleve, and warm bath. felt a little exhausted after side effects subsided.
Patient experienced a large area of erythema (19cm x 17.5cm) 1 day after injection at injection site
Patient received J+J on 4/10/2021 and then received Pfizer as documented in this report on 9/5/2021.
Started with numb feeling in my mouth, and that night my left eye wouldn't blink went to the ER  and gave me Acyclovir and gave me prednisone 10 mg, Still cant blink my left eye.
Patient was given the incorrect Pfizer vaccine for dose 1 and 2. Patient was given Bivalent instead of the  monovalent for dose 1 and 2. Patient received these on 11/21/2022 and 12/12/2022. The patients  parents have been notified of the error at a follow up visit by the Physician in the office. Patient reported no concerns.
This is in follow-up to report(s) previously submitted on 6/14/2007. Information has been received from a registered nurse concerning a 72 year old female with sulfa and baetadine allergies who on 26-APR-2007 was vaccinated in the right arm with a first dose of ZOSTAVAX (Merck) (656395/0290U). There was no concomitant medication. On 01-MAY-2007 (previously reported as 28-APR-2007) the patient experienced redness and was swollen on the site of injection. Three days later, on 03-MAY-2007, the patient's redness and swelling at the site of vaccine resolved. Additional information is not expected.
sleeping a lot; dreaming a lot; muscle pain in right arm; tiredness/ tiredness continues; Received 2nd dose of Moderna vaccine after 2 months of first dose; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (sleeping a lot), ABNORMAL DREAMS (dreaming a lot), MYALGIA (muscle pain in right arm), FATIGUE (tiredness/ tiredness continues) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received 2nd dose of Moderna vaccine after 2 months of first dose) in an 89-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     The patient's past medical history included Dizziness (near Fainting when BP was high. After taking Losartan and Amlodipine as blood pressure medications, the Dizziness and near fainting feelings went away.) and Fainting. Concomitant products included LOSARTAN and AMLODIPINE for Blood pressure, ATORVASTATIN CALCIUM (LIPITOR) and GEMFIBROZIL for Cholesterol, ASPIRIN [ACETYLSALICYLIC ACID], MULTIVITAMIN [VITAMINS NOS], VITAMIN B12 NOS and CARVEDILOL for an unknown indication.   On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received 2nd dose of Moderna vaccine after 2 months of first dose). On 26-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced SOMNOLENCE (sleeping a lot), ABNORMAL DREAMS (dreaming a lot), MYALGIA (muscle pain in right arm) and FATIGUE (tiredness/ tiredness continues). At the time of the report, SOMNOLENCE (sleeping a lot) and MYALGIA (muscle pain in right arm) outcome was unknown, ABNORMAL DREAMS (dreaming a lot) was resolving, FATIGUE (tiredness/ tiredness continues) had not resolved and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received 2nd dose of Moderna vaccine after 2 months of first dose) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In May 2021, Blood pressure measurement: 135 mmHg (Low) his cardiologist asked him to make a diary of Blood Pressure and take it to him. Lowest BP 135 mmHg and 165 mmHg (High) highest 165 mmHg.         No treatment medications provided by the reporter. The patient reported that Except for less dreaming, patient feeling the same as previously reported. Been seeing doctor who ordered tests especially a three-hour stress test which patient understood thru the nurse results are normal. Other important test (Ultrasound), no results obtained yet. Naturally, the uncertainty causes me anxiety.     Most recent FOLLOW-UP information incorporated above includes: On 06-May-2021: Follow up received &  updated Reporters contact details and contains non significant information. On 19-May-2021: Follow up received & updated past medical history, concomitant medications and event outcome for tiredness is still ongoing On 06-Aug-2021: Significant follow up received.
Red, itchy, bumpy rash on my stomach -- started Friday morning by Saturday became about 3" by .5" -- called doctor's office talked with an on-call RN who recommended ice and 1% hydrocortisone cream  Still resolving -- it is shrinking and the itchiness has subsided
190 patients (9 different lot numbers) received a vaccine past the beyond used by date; No Adverse Event; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (190 patients (9 different lot numbers) received a vaccine past the beyond used by date) and NO ADVERSE EVENT (No Adverse Event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (190 patients (9 different lot numbers) received a vaccine past the beyond used by date) and NO ADVERSE EVENT (No Adverse Event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (190 patients (9 different lot numbers) received a vaccine past the beyond used by date) and NO ADVERSE EVENT (No Adverse Event) outcome was unknown. Not Provided      For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse Event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (190 patients (9 different lot numbers) received a vaccine past the beyond used by date).    No concomitant medication was reported.  190 patients (9 different lot numbers) received a vaccine past the beyond used by date.  It was unknown if patient received any other vaccines in the 4 weeks prior to the COVID-19 vaccine administration.  No treatment medication was reported.  This case pertains to the 44th patient of the total 190 patients.   This case was linked to US-MODERNATX, INC.-MOD-2023-704335 (Linked Report).   Reporter did not allow further contact; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-704335:Master case
Mother reports 10-15 red flat spots on child's neck and chest. States child feels fine. No fever. Did not seek medical care.
This spontaneous report was received from a registered nurse refers to unspecified patients of unknown demographics. Information regarding medical history, concurrent conditions and drug reactions/allergies were not reported. On an unknown date, the patients were vaccinated with improperly stored M-M-R II (lot # L009214, expiry date: 17-MAR-2017). No adverse effects were reported. This is one of the three reports received from the same reporter. Additional information has been requested.
During administration of the vaccine, the syringe detached from the needle when the plunger was pushed. Some of the medication was administered and the remainder ran down the patient's arm. Patient was instructed to wait so an incident report could be completed. Patient was then administered another half dosage of the medication and instructed to wait 15 minutes in the parking lot.
Vasovagal response. Lightheaded  post Vasovagal. Vomited. Drank water, rested for about 60 mins and then felt better and was stable to leave vaccine site.
No major side effects but I have had a headache that is persistent for a couple days. I have taken tylenol which helps but the headache has been very persistent. It is still on and off on day 3 but getting better.
Joint pain; Pain at injection site; Fever of 100.4; This is a spontaneous report from a contactable healthcare professional. A 55-year-old male patient received first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EH9899), via an unspecified route of administration on 17Dec2020 14:00 in right arm at single dose for COVID-19 immunization. Medical history included allergies to Ovaltine from an unknown date and unknown if ongoing. Concomitant medication included atorvastatin calcium (LIPITOR). On 25Dec2020, the patient experienced pain at injection site x 2 days, fever of 100.4 and joint pain at day 7. The facility where the most recent COVID-19 vaccine was administered was in a military base. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The outcome of event pain at injection site was recovered in Dec2020 and the outcome of the remaining events was recovered on unspecified date. The event was considered non serious as it did not results in death, was not life threatening, did not cause/prolonged hospitalization, was not disabling/Incapacitating and had no congenital anomaly/birth defect.
Initial and follow up information has been received from a licensed pratical nurse and the mother of a 10 week old female infant with no medical history who on 04-DEC-2007 was vaccinated with a dose of PedvaxHIB. There was no concomitant medication. There was no illness at the time of vaccination.. On 05-DEC-2007 the patient developed diarrhea which persisted for 3 weeks. On 10-DEC-2007 the infant was hospitalized for fever and possible urinary tract infection; unspecified urine and blood tests were performed (results not provided). The patient was discharged on 11-DEC-2007. As of the report date, her diarrhea persisted. Additional information has been requested. This is in follow up to report (s) submitted on 2/14/2008. Urine cultures were negative for urinary tract infection. On 12-Dec-2007 laboratory diagnostic test were negative for rotavirus antigen. Urine cultures were negative for urinary tract infection. On 12-Dec-2007 laboratory diagnostic test were negative for rotavirus antigen. On 14-Dec-2007 stool cultures were negative for salmonella, shigella, campylobacto: and bacillus cereus. On 27-Dec-2008 stool cultures were again negative for salmonella, shigelia, campylobactor and giardia, C diff toxins were negative. The patient was discharged after 3 days. The patient recovered on 28-Dec-2007. No further information is available.
Child broke out in hives on back, stomach, face and legs a few hours after receiving a hepatitis A shot. I viewed an article online that stated children over 2 should receive this shot in 2 parts, 6 months apart. My son is only 15 months old.
This spontaneous report as received from a pharmacist refers to a female patient of unknown age. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On 01-NOV-2017, the patient was vaccinated with GARDASIL 9 (dose, site, route of administration, lot # and expiration date were not reported) for prophylaxis. On 01-NOV-2017, reported as the same day, the patient experienced pain, erythema, and swelling at site of injection. The patient sought medical attention. The reporter stated that the patient treated herself with an unspecified pain medication, ice and BENADRYL. The outcome of the events was reported as not recovered. The relatedness between GARDASIL and the events was unknown.
11/21/22 I was not feeling well. I was congested and lethargic. I then got a headache and body aches. I tested positive with an at home COVID test on 11/23/22. I called my doctor's office and they said I did not qualify for Paxlovid. I rested, drank fluids and did not start to feel better until 11/29/22.
Initial information received on 07-Mar-2019 regarding an unsolicited valid non-serious case received from Other health care professional via other company (Pfizer). This case involves an unknown age and gender patient who experienced allergy to tetanus vaccines and toxoid, while he/she received vaccine TETANUS TOXOID. The patients past medical history, concomitant medication and family history were not provided. On an unknown date, the patient received injection of suspect TETANUS TOXOID produced by unknown manufacturer lot number not reported via unknown route in unknown administration site. On an unknown date, the patient developed a non-serious allergy to tetanus vaccines and toxoid (allergy to vaccine) with unknown latency following the administration of TETANUS TOXOID. On an unknown date, the patient developed a non-serious hives (urticaria) with unknown latency following the administration of TETANUS TOXOID. Lab data was not provided. Final diagnosis was allergy to tetanus vaccines and toxoid. It was not reported if the patient received a corrective treatment. The patient outcome is reported as Unknown for allergy to tetanus vaccines and toxoid and as Unknown for hives. List of documents held by sender- none.
Fever last night of 102.3; cold chills; aches; extreme fatigue; loss of appetite; This is a spontaneous report from a contactable other healthcare professional (patient). A 41-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot/batch number and expiration date not reported) via an unspecified route of administration on the left arm on 24Jan2021 09:00 at a single dose for COVID-19 immunization. Medical history included asthma. Concomitant medication included valaciclovir hydrochloride (VALTREX). The patient previously took acetylsalicylic acid (ASPIRIN) and hydrocododone and experienced allergies. The patient experienced cold chills and aches, extreme fatigue, loss of appetite on 26Jan2021 10:00 AM. At days 5-7, my symptoms went from to strongly moderate. Fever last night (30Jan2021) of 102.3. No treatment was received for the events. Patient was not pregnant. Prior to vaccination, the patient was not diagnosed with COVID-19. Post vaccination, the patient has not been tested for COVID-19. Outcome of the events was not recovered.  Information on the lot/batch number has been requested.
1 week after receiving his 2nd dose of the Moderna vaccine he developed a severe rash at the site of the vaccine.  It is now 10 months since receiving the vaccine and he still has a rash at the site.  Violaceous annular plaque 3cm x 3 cm on left upper arm.  I have photos.
Headache, Myalgia, Diarrhea & NauseaVomiting Narrative:   Other Relevant History:
On October 27, 2008 flu vaccine administered to deltoid region of left arm at around 3:30pm. Mom called on October 28th to report redness and induration at the site. She come in at 3:15 on the 28th to be seen by Dr. The area was noted by Dr. to have a reddened area about 3 1/2 to 4 inches around the injection site and a moderately sized hive near the site. The doctor ordered benedryl 25mg 3-4 times/day and ice to the site. PHN spoke with Dad on 10/31. Dad reports arm is completely cleared.
Pfizer COVID vaccine 2nd dose given 14 days after 1st dose, should be 21 days.
Information has been received from the registered nurse concerning to an approximately 5 year old patient of unknown gender. Patient's concurrent conditions and relevant medical history was not reported. On 10-APR-2015, the patient was vaccinated with improperly stored MMR II (lot number: K001230 with unknown expiration date (dose, route and frequency unspecified). Concomitant medications were not reported. No adverse event was reported. The outcome of the event was unknown. The causality of the events with MMR II was not reported. This is one of the several reports from the same reporter. Additional information has been requested.
Red area 9 x 9 cm right outer thigh. Fever (100.7) and vomiting (x3)
This spontaneous report as received from a medical assistant, refers to multiple patients of unknown demography. No concurrent condition, medical history or allergy/drug reactions were reported. On an unspecified date, multiple unspecified patients were vaccinated with improperly stored GARDASIL injection (strength, dose, route and lot number or batch number unspecified). No concomitant medications were reported. No adverse effects were reported. The outcome of the event was unknown. There were no product quality complaints (PQC) involved. No further information was provided. This is one of several reports received from the same reporter. Additional information has been requested.
Patient complained of feeling drowsy, fatigued and having a  dry mouth after receiving the vaccine.  Patient was taken to an exam room and given water to drink.  Vitals were taken and blood pressure was noted to be high, reading at 166/114 at 4:10pm.  Patient was placed on exam bed in prone position to rest. Vitals taken again at 4:31 and read 166/99.  Patient stated that she was very anxious about getting the vaccine.  Patient was evaluated by, FNP and instructed to follow-up with her primary care provider as patient denied having high blood pressure.  Patient stated she was feeling better and was discharged at 4:50pm.
2 recipients who got the vaccine were 16 and 17; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (2 recipients who got the vaccine were 16 and 17) in a 17-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jul-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (2 recipients who got the vaccine were 16 and 17). On 29-Jul-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (2 recipients who got the vaccine were 16 and 17) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  Treatment information was not provided.  No adverse reactions had been reported by the patient.   This case was linked to MOD-2021-271735 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 30-Jul-2021: Follow-up received contains updated contact details of reporter.
Adult Pfizer diluted with 1.3ml (pediatric dose) of diluent instead of 1.8ml.
Patient-reported rash and hives around  stomach, arms, neck and hands.  The patient took Benadryl.  Patient-reported rash went away
CLIENT BEGAN TO HAVE RAPID HEART RATE, SCRATCHY THROAT, AND FELT TISSUE AROUND LEFT EYE SWELLING APPROX 10  MIN AFTER VACCINATION.  HAD PREMEDICATED WITH DIPHENHYDRAMINE 25MG PRE-VACCINATION.  WAS GIVEN 50 MG DIPHENYDRAMINE LIQUID PO 10 MIN POST VACCINATION WHEN CLIENT REPORTED S/S.  HR WAS 160.  CLIENT WAITED 30 MIN AFTER S/S ONSET.  REPORTS S/S RESOLVED.  HR 114.  CLIENT LEFT CLINIC IN NO ACUTE DISTRESS.  CLIENT WAS CONTACTED THAT EVENING AND REPORTED NO DISTRESS.
Redness, heat and edema in right deltoid area day 2 after vaccine (shoulder to elbow), pain in shoulder area.  Day 5 (12/22/03) after vaccine no pain, slight edema, some areas of redness on upper arm and near elbow, cool to touch, to consult MD as needed.
Headache, Fever, ErythemaMultiform, arm pain, fatigue Narrative:
Information had been received on 21-OCT-2016 from a registered nurse regarding a case for GARDASIL 9 (MARRS# 1610USA012312). The registered nurse reported that on 17-OCT-2016 a male patient (age unknown) received an improperly stored dose of GARDASIL 9 (lot# M017983, expiration date 30-APR-2018). Temperature was 57.7F at time frame of 14 hours. Call was because of a data logger. There was no previous temperature excursion. No adverse effects reported. No further details provided. This is one of two reports from the same reporter. Additional information has been requested.
pt recv vax 19SEP96 & on 21SEP96 pt devel a vesicular rash @ the inj site & a fever;
Headache, dizzy, nausea, stiffness in joints. Stomach cramps, vision impairment. Mild flashes.
not feeling well; This is a spontaneous report from a contactable consumer (patient's husband). A 83-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 14Jan2021 (yesterday) at single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient was not feeling well in Jan2021 with outcome of unknown.   Pfizer is a marketing authorization holder of [BNT162B2] in the country of incidence or the country where the product was purchased (if different). This may be a duplicate report if another marketing authorization holder of [BNT162B2] has submitted the same report to the regulatory authorities.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information expected.
minimal blood spotting; This spontaneous case was reported by a consumer and describes the occurrence of VAGINAL HAEMORRHAGE (minimal blood spotting) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     Concomitant products included ESOMEPRAZOLE SODIUM (NEXIUM [ESOMEPRAZOLE SODIUM]) for Acid reflux (esophageal), ROSUVASTATIN for Cholesterol, GABAPENTIN for Neuropathy, NAPROXEN for Pain.   On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Apr-2021, the patient experienced VAGINAL HAEMORRHAGE (minimal blood spotting). At the time of the report, VAGINAL HAEMORRHAGE (minimal blood spotting) outcome was unknown. Not Provided          No treatment information was provided. Action taken with mRNA-1273 in response to the events was not applicable.
PATIENT UNKNOWINGLY RECEIVED DOSE FOR THE 2ND TIME IN 3 DAYS
started to fill itchy over all over body and slight headache. started about 10 minutes after vaccination.
Five days after my vaccine, I experienced itchiness to my skin and body. I talked to my doctor about my symptoms and he does not know what caused my skin itchiness. He recommended for me take Benadryl and allergy medication. He also gave me a steroid but I could not take it since I am allergic to the steroids.  I want to find out why after my vaccine, my whole body and skin is itchy. I still have the itchiness today and it does not want to go away.
it was rpt from HCP concerning pt who in aug97 was vax w/pneumococcal; there was no concomitant med; in oct97 pt recv 2nd dose of vax; addl info recv indicated pt exp ``no react other than little soreness at inj site''